Drug
Elvucitabine
Elvucitabine: highest development phase Phase 1/2, developed by Alexion. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1/2
- Developer
- Alexion
Trials
| Drug | Phase | Indication |
|---|---|---|
| Elvucitabine NCT00312039 | Phase 1/2 | HIV Infections |
Latest
No recent events.
Follow Elvucitabine on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.